Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Sanford-Burnham's Conrad Prebys Center for Chemical Genomics Using Genedata Screener

Published: Wednesday, April 25, 2012
Last Updated: Wednesday, April 25, 2012
Bookmark and Share
Genedata Screener® provides enterprise platform for data analysis of High-Content Screening and High-Throughput Screening campaigns across multiple sites

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Genedata Screener® is in full production at the Conrad Prebys Center for Chemical Genomics at Sanford-Burnham Medical Research Institute. The Conrad Prebys Center, a premier academic facility for chemical probe and drug discovery, conducts extensive High-Content Screening (HCS) and High-Throughput Screening (HTS) at two sites of operation (La Jolla, CA and Lake Nona in Orlando, FL). Facility-wide, Genedata Screener is the standard platform for all screening campaigns from libraries totaling nearly one million chemical compounds and natural products.

"To find more sophisticated ways to build a drug pipeline, we wanted to advance our research capabilities from an informatics perspective," noted Dr. Christian Hassig, director of Drug Discovery at the Conrad Prebys Center. "Genedata Screener has helped us build an advanced IT infrastructure."

Accessing Unexplored Biology
"Screener helps us to access unexplored biology that can't be examined any other way," continued Hassig. "It enables our scientists to better process HCS and HTS data and identifies potentially valuable hits that may otherwise be lost. Overall, Screener helps us determine the best datasets for hit selection, which is a huge differentiator for us."

Compatible with all leading HCS instruments and image management systems, Genedata Screener for HCS covers the complete HCS data analysis workflow from cell-level data to final campaign results. It is used on all HCS projects at the Conrad Prebys Center, which is home to three major compound libraries, including the collections from Molecular Libraries Probe Production Centers Network (364,000 compounds), Sanford-Burnham's collection (325,000 compounds), and the National Cancer Institute's Natural Product Extraction collection (150,000 compounds), as well as numerous small molecule specialty collections.

"Genedata Screener improves the quality of our data analysis," said Dr. Susanne Heynen-Genel, director of the HCS Core Facility at the Conrad Prebys Center, which provides assay development and screening services on imaging-compatible microtiter plates. She cites that "with Genedata Screener, we can link image displays to scatter plots, select outliers from scatter plots, easily identify and weed-out artifacts, and simultaneously handle multiple parameters in a single window." Capabilities such as these eliminate tedious manual handling of single plates and the lag time traditionally experienced when accessing different systems and files. "Genedata brings our data analysis to a new level and gives us a lot of confidence in the final data we deliver to investigators," continued Heynen-Genel.
The Conrad Prebys Center's Lake Nona, Orlando facility for HTS conducts chemical library screening of biological targets to help in selecting and implementing suitable biochemical or cellular assays. Monthly, the Lake Nona facility typically handles 2 to 3 HTS campaigns of more than 350,000 compounds each.

"Genedata Screener has become part of our daily workflow," commented Dr. Ying Su, director of Cheminformatics and HTS Informatics at the Conrad Prebys Center. "Prior to Genedata Screener, we ran plate-by-plate analysis, which is not only time-consuming, but makes it difficult to detect systematic errors. With Genedata, we have an overview of the hit map for each plate and are effectively reducing false-negatives. I believe Screener is the leading software for HTS data handling."

"We are excited about our collaboration with Sanford-Burnham, which is at the cutting edge in discovering molecular causes of diseases and devising therapies to address them," said Dr. Othmar Pfannes, CEO of Genedata. "The depth and breadth of their HCS and HTS campaigns underscores the value Genedata Screener brings to organizations looking at a wide variety of technologies and workflows.  We will continue to advance Screener's capabilities to support HCS and other innovative technologies that enable collaborative and pioneering research."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GSK Implements Genedata Biologics as Antibody Discovery Platform
Genedata Biologics integrates GlaxoSmithKline's Biopharm Discovery workflows across multiple Biopharm R&D groups and sites
Thursday, June 12, 2014
Genedata Showcases Integrated Analysis & Image Management Solution for Phenotypic Screening
Regardless of instrument or application, Genedata Screener® for High Content Screening enables time-efficient workflow for analysis of high-content experiments
Friday, February 21, 2014
Genedata Announces New Data Analysis Platform for Next-Gen Oncology Drug Discovery
AstraZeneca and Genedata detail a data analysis platform for compound combination experiments in oncology and other therapeutic areas
Monday, February 03, 2014
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Chooses Genedata Expressionist for Oncology Research
Leading clinical-research institute of the Robert Bosch Stiftung uses Genedata Expressionist for managing, processing, and interpreting clinical NGS data
Monday, January 27, 2014
Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization
Genedata Selector platform to manage, analyze, and integrate complex microbial genomes and strains will be showcased in 5th Annual NGS Conference Poster Session
Saturday, November 23, 2013
Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
Genedata Biologics will be implemented at multiple Sanofi R&D sites and departments to improve biologics discovery throughput and process efficiency.
Sunday, November 10, 2013
Evonik and Genedata broaden their collaboration with the Genedata Selector biotechnology data management platform
Genomic strain data management solution supports Evonik growth in biotechnology
Sunday, September 22, 2013
AB SCIEX, Genedata and LECO Announce Partnership
New collaborative software system will enable metabolomics researchers to comprehensively process and analyze experimental data across different GC/MS and LC/MS platforms.
Tuesday, July 02, 2013
Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
Genedata collaborates with leading European institutions on the development of blood tests for early detection of major female cancers based on epigenetic markers
Saturday, April 06, 2013
Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
Genedata Expressionist will be demonstrated as a platform for automating and standardizing protein characterization that helps eliminate data analysis bottlenecks
Wednesday, March 13, 2013
Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
Global leader in drug discovery advances targeted proteomics and metabolomics with extended use of Genedata Expressionist®
Sunday, February 10, 2013
Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
More than half of the top 25 pharmaceutical companies now use Genedata Screener® to support plate-based screening, including High Content, Label-free, and Ion Channel Screening
Sunday, January 20, 2013
Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
carcinoGENOMICS and other EU-funded research consortia help Genedata advance software platform
Friday, December 28, 2012
Genedata Biologics for Streamlined Protein Engineering at PEGS Europe
UCB Pharma and Genedata will showcase data management and workflow system that captures production and characterization data for biotherapeutics and reagents
Sunday, November 11, 2012
UCB Pharma Advances Next-Generation Antibody Discovery with Genedata Biologics
Leader in protein therapeutics development extends use of Genedata Biologics for next-generation antibody-based therapeutics R&D
Thursday, September 20, 2012
Scientific News
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
Breaking Through the Barriers to Lab Innovation
Here we examine the drivers behind the move for greater innovation, the challenges and current trends in laboratory informatics, and the tools that can be used to break these barriers.
Researchers Construct Atomic Model of an Immature Retrovirus
Using molecular modeling and large-scale molecular dynamic simulation, Beckman researchers have constructed an atomic model of an immature retrovirus.
New Mathematics Advances the Frontier of Macromolecular Imaging
Berkeley Lab’s M-TIP solves the reconstruction problem for fluctuation X-ray scattering.
Exploring Living cells
JPK reports the exploration of living cells using nanoscale and single molecule techniques through the application of scanning probe microscopy.
The Perfect Partnership: Research & Industry; Software & Instrumentation. It really starts to come together at ASMS 2015
Collaboration and knowledge-sharing were evident everywhere: on the bus, in the hallways and in the bars. This article aims to capture this theme and share with you some of the fruits of this coming together of science and industry.
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
Antibody Pries Loose Bacteria’s Grip
Study finds novel method of improving antibody efficacy.
CLAIRE Brings Electron Microscopy to Soft Materials
CLAIRE works by essentially combining the best attributes of optical and scanning electron microscopy into a single imaging platform.
Sample & Analysis Tracking in Oncogenomic Experiments
The study outlines Onco-STS, a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos